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ReviewMetabolic intermediates e Cellular messengers
talking to chromatin modiﬁersAnna Nieborak 1, Robert Schneider 1,2,*ABSTRACT
Background: To maintain homeostasis, cells need to coordinate the expression of their genes. Epigenetic mechanisms controlling transcription
activation and repression include DNA methylation and post-translational modiﬁcations of histones, which can affect the architecture of chromatin
and/or create ’docking platforms’ for multiple binding proteins. These modiﬁcations can be dynamically set and removed by various enzymes that
depend on the availability of key metabolites derived from different intracellular pathways. Therefore, small metabolites generated in anabolic and
catabolic processes can integrate multiple external and internal stimuli and transfer information on the energetic state of a cell to the tran-
scriptional machinery by regulating the activity of chromatin-modifying enzymes.
Scope of review: This review provides an overview of the current literature and concepts on the connections and crosstalk between key cellular
metabolites, enzymes responsible for their synthesis, recycling, and conversion and chromatin marks controlling gene expression.
Major conclusions: Whereas current evidence indicates that many chromatin-modifying enzymes respond to alterations in the levels of their
cofactors, cosubstrates, and inhibitors, the detailed molecular mechanisms and functional consequences of such processes are largely unre-
solved. A deeper investigation of mechanisms responsible for altering the total cellular concentration of particular metabolites, as well as their
nuclear abundance and accessibility for chromatin-modifying enzymes, will be necessary to better understand the crosstalk between metabolism,
chromatin marks, and gene expression.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The term ‘epigenetics’ was originally coined by Waddington in 1942
[1]; however, the usage and deﬁnition of ‘epigenetics’ has changed
throughout the years. The Greek preﬁx ‘epi-’ (meaning ‘over’ or
‘above’) emphasizes phenomena that reach beyond well established
genetic (DNA sequence based) mechanisms. In the same notion, in
2008, an ‘epigenetic trait’ was deﬁned as a ‘stably heritable phenotype
resulting from changes in a chromosome without alterations in the
DNA sequence’ [2]. Therefore, one of the key implications of ‘epige-
netics’ is that a cell can preserve a memory of past states and signals,
triggering its future behavior, in the absence of both the initial signal
and alterations in the DNA sequence.
In multicellular organisms epigenetic factors can enable cells to acti-
vate or repress particular sets of genes. There are several mechanisms
that are implicated in mediating inheritance and maintenance of such
gene expression states. The most common mechanisms, and the only
ones discussed in this review, are covalent modiﬁcations of chromatin.
This review focuses on a new aspect of ‘epigenetics’, the link between
the metabolic state of a cell and chromatin architecture. In particular it
discusses the metabolites, generated and converted in various phys-
iological pathways, which are of great importance to many epigenetic
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www.molecularmetabolism.comketoglutarate (a-KG), succinate, fumarate, acetyl-CoA, short chain
acyl-CoAs and NADþ. We summarize the existing body of knowledge
on metabolism of the aforementioned compounds, their subcellular
localization and impact on chromatin modiﬁcation and, thus, gene
expression. Although many aspects of the links between metabolism
and epigenetics have been excellently reviewed elsewhere (see for
example: [3e11]), here we touch on frequently neglected aspects of
subcellular distribution of metabolites and enzymes as well as on ki-
netic parameters of chromatin-modifying enzymes and on physiolog-
ical concentrations of key cofactors. Finally, we highlight the existing
gaps in the ﬁeld and suggest potential future directions.2. EPIGENETIC MECHANISMS REGULATING CHROMATIN
FUNCTIONS
Early studies in mouse revealed that a modiﬁcation of DNA itself, DNA
methylation, could act as an ‘epigenetic’ mark, for example in X chro-
mosome inactivation [12]. The discovery of enzymatic semi-
conservative propagation of such DNA methylation patterns at CpG
sites after replication and mitotic division gave the ﬁrst insights into how
such ‘epigenetic’ information could bemaintained through cell divisions.
Attention is now being focused on the possible transgenerational
transmission of these patterns, the contribution of DNA methylation toGermany 2Faculty of Biology, LMU, 82152 Martinsried, Germany
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Reviewgene silencing, mechanisms initiating or preventing methylation on fully
unmethylated sites, and the enzymes catalyzing this modiﬁcation [13].
DNA methylation patterns are not static and can be highly dynamic; for
example, during preimplantation development, major changes in DNA
methylation patterns occur in the mammalian genome. In the preim-
plantation state, methylation marks on both the maternal and paternal
DNA are largely erased and subsequently reestablished de novo. This
requires another set of enzymes, different from the ones responsible
for maintenance of CpG methylation in somatic cells.
Eukaryotic DNA exists as a complex of DNA and proteins, which are
collectively the chromatin. The most abundant proteins in chromatin
are histones, discovered by Kossel in the nineteenth century [14].
Histones, the main structural components of eukaryotic chromatin, are
highly basic proteins that, together with the DNA wrapped around
them, form nucleosomes. Initial suggestions that histones are merely
general repressors of gene expression were reﬁned after a break-
through discovery by Allfrey and Mirsky in 1964; they showed that
histones can be modiﬁed by lysine acetylation and that this acetylation
is positively correlated with gene activation [15]. Since that time, in-
terest in histone modiﬁcations and their role in gene expression have
been growing. The functional signiﬁcance of various chemical groups
attached to histones became clearer when the structure of the
nucleosomal core particle was determined [16]. The nucleosomal core
particle is composed of 147 bp of DNA wrapped around a histone
octamer consisting of 2 copies of each of the core histones: H2A, H2B,
H3, and H4, with their globular domains forming a ‘spool’ for the DNA
and the terminal tails protruding from the core of nucleosome. Histone
H1, also known as the linker histone, binds to the linker DNA region
between nucleosomal core particles.
Chromatin architecture and dynamics contribute signiﬁcantly to gene
expression. A wide range of histone post-translational modiﬁcations
(PTMs) plays an important role in establishing various chromatin states.
This may be achieved by both changing the physical properties of
nucleosomes and by recruiting different binding proteins that then exert
effects on downstream events such as transcription. Some of the most
studied histone PTMs are phosphorylation, methylation, acetylation,
and ubiquitylation, thoroughly reviewed in [17e20]. Additionally, novel
histone modiﬁcations are continuously being identiﬁed. It is now known
that histone PTMs contribute to the mechanisms by which DNA-
sequence speciﬁc transcription factors and additional transcriptional
regulators modulate expression and silencing of genes. One of the ﬁrst
examples supporting this notion came from the work on a yeast protein
Gcn5, a component of the SAGA complex, previously associated with
active transcription. Gcn5 was shown to possess histone acetyl-
transferase activity and hence to act as a ‘writer’ of histone modiﬁ-
cations [21]. Acetylation of lysines within N-terminal histone tails is
highly enriched at the promoter regions of genes and is generally
associated with chromatin decompaction, promoting high levels of
gene expression. The function of histone methylation on lysines and
arginines and its contribution to gene expression depends on the
modiﬁed residue. For example, mono- and tri-methylations are found
to be enriched on active promoters (e.g. H3K4me3), active enhancers
(H3K4me1), inactive promoters (e.g. H3K27me3) and coding regions of
active genes (e.g. H3K36me3). Most histone modiﬁcations are
reversible and can be removed by so-called ‘erasers’. The combined
range of histone PTMs and DNA modiﬁcations can constitute particular
epigenetic patterns that can be speciﬁcally recognized and bound by
so-called ‘reader’ proteins. Some of these readers have their own
histone-modifying activity, where their role can be to recognize and
bind a particular PTM, introduce the same mark onto the adjacent
nucleosome and thus propagate a particular modiﬁcation in a deﬁned40 MOLECULAR METABOLISM 14 (2018) 39e52  2018 The Authors. Published by Elsevier GmbH. Thiregion of the genome [22]. Other ‘readers’ can be e.g. subunits of ATP-
dependent chromatin-remodeling complexes that modulate gene
expression by ejecting or ‘sliding’ nucleosomes. Combinatorial patterns
of histone PTMs are crucial determinants of the state and architecture
of chromatin e that can be accessible to transcription, DNA repair and
replication or compacted and usually devoid of transcribed genes.
Apart from recruiting ‘reader’ proteins, some histone PTMs have been
shown to affect the structure or dynamics of chromatin on their own.
These effects are mainly observed for modiﬁcations of residues within
globular domains of histones. Acetylation of H3K64 by p300 de-
stabilizes nucleosomes and can promote histone eviction and tran-
scription [23]. Similarly, acetylation of H3K122, a residue that
physically interacts with DNA and thus has been anticipated to affect
nucleosome stability, stimulates transcription of in vitro assembled
chromatin [24,25]. Acetylation of H4K16 is so far the only tail modi-
ﬁcation that directly affects chromatin structure [26] e when incor-
porated into in vitro reconstituted nucleosomal arrays, this modiﬁcation
was shown to prevent chromatin from forming higher order structures.
Since covalent modiﬁcations of chromatin components underlie gene
expression programs, the activity of the enzymes responsible for
placing these modiﬁcations and their removal can be a crucial factor
controlling transcription. In the last few years it has become evident
that small metabolic intermediates can be common denominators
between two elementary biological processes: energy metabolism and
gene regulation. Cells in a particular metabolic condition established by
available nutrients, external stimulation and their intrinsic metabolic
status, produce speciﬁc sets of metabolites, many of which can serve
as cofactors or inhibitors of chromatin-modifying enzymes and hence
regulate their activity or speciﬁcity (Figure 1).
3. SAM AS A COMMON COFACTOR FOR METHYLATION OF
CHROMATIN
3.1. DNA and RNA methylation as epigenetic marks
Methylation of DNA was ﬁrst reported in 1963 [27]. Since the discovery
that hypo-methylation of particular genes is associated with some
human cancers, its role in normal human development, aging and
tumorigenesis has been thoroughly explored [28,29]. Enzymatic
transfer of a methyl group to the C-5 position of the cytosine is cat-
alysed by DNA methyltransferases (DNMTs), of which are three main
ones in mammals: DNMT3A, DNMT3B and DNMT1. While DNMT3A/B
are mainly responsible for setting de novo methylation patterns (e.g. in
early embryo development) and are able to methylate non-methylated
cytosines, DNMT1 e the most abundant methyltransferase e acts
predominantly on hemi-methylated CpG dinucleotides and thus pro-
vides stability of methylation patterns after DNA replication through cell
division, making DNA methylation a truly ‘epigenetic’ mark [30,31].
From the more than 100 various covalent modiﬁcations of RNA that
have been identiﬁed, methylation of adenine at the N-6 position (m6A)
is the most prevalent in eukaryotic mRNA [32]. Although studies have
reported different effects of m6A on RNA functions and correlations
between alterations in m6A patterns and various human diseases,
including many cancers, its functional role is just emerging and needs
further investigation [33].
3.2. Histone methylation can repress or activate transcription
The catalogue of histone methylation states is ample as methylation
can occur on lysine (Lys), arginine (Arg) and histidine (His) residues.
Moreover each Lys residue can carry one, two or three methyl groups
(mono-, di- and tri-methylation, respectively) and each arginine can be
mono- and symmetrically or asymmetrically di-methylated. The mosts is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
Figure 1: Crosstalk between metabolism and chromatin modiﬁcations. Cells supplied with external energy sources are in a metabolic state with distinct intermediary metabolites
generated by metabolic enzymes (ME). Many of these metabolic intermediates can serve as cofactors or inhibitors of chromatin modiﬁers e such as ‘hubs’ collecting intra- and
extracellular signals and transferring them to the chromatin level and thus affecting transcriptional events; 2-HG e 2-hydroxyglutarate, NADH e reduced form of nicotinamide
adenine dinucleotide; NADþ - oxidized form of nicotinamide adenine dinucleotide, NAM e nicotinamide, TCA e tricarboxylic acid cycle, a-KG e a-ketoglutarate, b-OHB e b-
hydroxybutyrate, b-ox e b-oxidation.studied histone methylation sites include: H3K4, H3K9, H3K27, H3K36,
H3K79, H4K20, H3R2, H3R8, H3R17, H3R26 and H4R3 [18].
There are two major families of histone methyltransferases that set
these modiﬁcations: Lys- and Arg-speciﬁc methyltransferases.
Although describing the domain structure, speciﬁcity and preference of
all the members of each family is beyond the scope of this article, the
common feature of all aforementioned histone methyltransferases, as
well as DNMTs, is necessity of the cofactor SAM to perform their
enzymatic function (Figure 2A). SAM is synthesised directly from
methionine (Met) by S-adenosylmethionine synthetases (see below).
For humans Met is an essential amino acid, however it can be recycled
in the methionine cycle from S-adenosylhomocysteine (SAH) via homo-
cysteine (homoCys) with a supply of methyl-tetrahydrofolate (methyl-
THF) derived from other amino acids (threonine (Thr), glycine (Gly),
serine (Ser)) and folic acid. In the liver and kidney Met can also be
synthesised from homo-cysteine with betaine as a methyl donor [34].
3.3. Metabolic impact on DNA methylation
One interesting example of a connection between diet and DNA
methylation observed in mice is the effect of folate in the mothers’ diet
on the phenotype of their offspring. Insertion of a repetitive element, an
intra-cisternal A particle (IAP) retrotransposon, into the 50 end of the
agouti gene results in the agouti viable yellow phenotype (Avy),
affecting the colour of the mice. The penetrance of the Avy phenotype
depends on the CpG methylation level of the IAP retrotransposon; high
methylation correlates with low expression of Avy (agouti-coloured
mice) while low methylation correlates with high expression of Avy
(yellow-coloured mice). Females whose diet was supplemented with
methyl donors gave birth to offspring with increased eumelanic
mottling (agouti/black areas on yellow background) compared to the
control group showing that dietary intake of methyl donors can
regulate the state of chromatin marks [35].
Studies in mouse embryonic stem cells (mESCs) provide another
example linking the cellular metabolic state, via concentrations of
compounds involved in the methionine cycle, to chromatin modiﬁca-
tions. Mitochondrial threonine dehydrogenase (Tdh) generates Gly andMOLECULAR METABOLISM 14 (2018) 39e52  2018 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comthus supplies the one-carbonmetabolismwithmethyl groups. Depletion
of Thr from the culture medium or knockdown of Tdh decreases SAM
concentrations as well as the levels of di- and tri-methylation of H3K4.
Moreover, mESCs show higher expression levels of Tdh in comparison
to differentiated cells [36], and Thr restriction leads to slowed growth
and increased differentiation. Remarkably, other modiﬁcations like
H3K4me1, H3K9me3, H3K27me3, H3K36me3 and H3K79me3, were
not affected by the knockdown, which could imply distinct sensitivity of
different histone Lys methyltransferases (KMTs) for SAM levels [37]. It is
not known if Thr metabolism has the same impact on histone Lys
methylation levels in human ESC where TDH is a non-functional tran-
scribed pseudogene [38] and Thr conversion is catalysed by L-Ser/Thr
dehydratase, whose role in one-carbon metabolism has not been fully
investigated. Nevertheless, Met restriction leads to a reduction in
H3K4me3 levels across a panel of human cancerous cell lines, clearly
demonstrating the importance of metabolism of particular amino acids
in regulatory histone methylation [39].
3.4. Methionine adenosyltransferases are required for SAM
biosynthesis
Synthesis of SAM, a cofactor for all methylation reactions, requires Met
and ATP and is catalysed by methionine adenosyltransferases (MATs).
There are 3 MAT isozymes in mammals (Figure 2E). Two genes encode
homologous, but different, MAT catalytic subunits. MAT1A, mostly
expressed in liver, encodes the a1 subunit found in two native MAT
isozymes, which are either a tetramer (MAT I) or dimer (MAT III) of this
subunit. MAT2A is expressed in many tissues including brain, kidney,
testis, lymphocytes, foetal liver and, to a lesser extent, adult liver. The
catalytic subunit it encodes (a2) is found in a native MAT isozyme (MAT
II) associated with the catalytically inactive, regulatory subunit b
encoded by MAT2B.
Impaired enzymatic activity of MATs has a profound effect on histone
methylation in many organisms. Depletion of MAT2A in immortalised
mouse embryonic ﬁbroblasts (iMEF) signiﬁcantly reduces tri-
methylation levels of H3K4 and H3K9 on a genome-wide scale
without affecting the levels of mono- and di-methylation of these sitesn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 41
Figure 2: Metabolites are involved in methylation and demethylation of chromatin; a. The interplay between folate and Met-homoCys cycles. Dietary or de novo synthesized folate and (in organisms expressing Tdh e in green) Thr supply the folate
cycle with THF and methylene-THF, respectively. This cycle generates methyl-THF subsequently used as a donor of the methyl group in the Met-homoCys cycle. In liver and kidney betaine, instead of methyl-THF, serves as a methyl donor; Cys e
cysteine, homoCys e homocysteine, Gly e glycine, Met e methionine, MTHFR e methylene-THF reductase, SAH e S-adenosylhomocysteine, SAM e S-adenosylmethionine, Tdh e threonine dehydrogenase, THF e tetrahydrofolate, Thr e
threonine; b. The FAD dependent demethylation of Lys occurs through the two electron oxidation of an amine by ﬂavin followed by the hydrolysis of an iminium ion; c. The Fe(II) dependent demethylation of trimethyl-Lys occurs through an Fe(II),
a-KG, and O2 derived radical oxidation of the methyl CeH bond; d. 5-mC conversion by TET enzymes. All intermediary products could be passively removed e.g. by DNA replication; 5-mC e 5-methylcytosine, 5-hmC e 5-hydroxymethylcytosine,
5-fC e 5-formylcytosine, 5-caC e 5-carboxycytosine, BER e base excision repair; e. Summary of human methionine adenosyltransferase genes and gene products.
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[40]. In Caenorhabditis elegans, knockdown of sam1 (homologue of
mammalian MAT2A) reduces H3K4me3 levels [41]. Simultaneous
knockdown of sam3 and sam4 leads to a reduction in H3K9me3,
H3K27me3 and H3K36me3 but does not affect H3K4me3 [42]. Simi-
larly, H3K4me3 but not H3K4me1, H3K4me2, H3K36me3 nor
H3K79me3 was reduced upon knockout of the yeast homologues of
MATse sam1 and sam2 [43]. Taken together, these ﬁndings raise the
possibility that (in particular tissues) the activity of speciﬁc subsets of
KMTs could depend on MAT activity. Interestingly it was shown that in
mammals the recruitment of MATII to the cyclooxygenase 2 (COX-2)
locus provides a local supply of SAM for the H3K9 methyltransferase
SETDB1 and represses the expression of COX-2 [40]. In addition to
these functional links between KMTs and MATs, studies in yeast
identiﬁed a protein complex SESAME consisting of multiple metabolic
enzymes including SAM synthetases and the Set1 KMT catalysing
H3K4 methylation [43]. Thus, recruitment of the SESAME complex
containing both KMT and SAM synthetases to target genes brings both
chromatin modiﬁers and the enzymes responsible for generating the
required cofactor in close proximity, creating a local ‘chromatin niche’
(or ‘chromatin microdomain’) with increased local concentration of
SAM used for histone methylation [6]. Whether the same mechanism
also exists in higher eukaryotes is still not known.
4. METABOLITES CRUCIAL FOR CHROMATIN DEMETHYLATION
4.1. Lysine-speciﬁc histone demethylase 1 and 2 (LSD)
Methylation of Lys residues was long believed to be irreversible, but
ﬁnally in 2004, the ﬁrst Lys demethylase (KDM) was identiﬁed and
named LSD1 (Lys-speciﬁc demethylase 1) [44]. It is a ﬂavin-dependent
amino oxidase speciﬁcally demethylating mono- and di-methylated
H3K4 (Figure 2B). Recently, LSD2, another ﬂavin-dependent KDM
acting on the same residue, has been identiﬁed in mammals [45]. The
catalytic mechanism of LSD1/2 involves forming an imine intermediate
and thus does not allow them to remove methyl groups from tri-
methylated Lys.
4.2. Fe2þ and a-ketoglutarate dependent dioxygenases can also
demethylate histones
The largest class of histone demethylases are Jumonji C (JmjC)
domain-containing demethylases, which belong to the bigger family of
Fe2þ and a-KG dependent dioxygenases (2-OGDO) and are grouped
into several subfamilies. The catalytic mechanism is different from the
previously mentioned amino oxidases. JmjC demethylases can remove
methyl groups from mono-, di- and tri-methylated Lys, forming
intermediary hydroxymethyl-Lys (Figure 2C).
4.3. Ten-eleven translocation enzymes modify DNA
For many years there was a notion that the loss of methyl marks on C-5
cytosine occurred through ‘passive dilution’ during DNA replication and
DNA repair processes. The discovery that Ten-eleven translocation
(TET) enzymes, previously associated with translocations in some
types of cancer, catalyse iterative conversion of 5-methylcytosine (5-
mC) shed new light on DNA demethylation mechanisms (Figure 2D)
[46]. The catalytic mechanism of TET enzymes is similar to JmjC
demethylases e they use oxygen to decarboxylate a-KG, generating a
high-valent iron oxide converting 5-methyl- (5-m-) to 5-
hydroxymethyl- (5-hm-) and further to 5-formyl- (5-f-) and 5-
carboxycytosine (5-caC), which can subsequently be removed
through base excision repair (BER) [47]. Apart from serving as an
intermediary product in the demethylation process, 5-hmC itself hasMOLECULAR METABOLISM 14 (2018) 39e52  2018 The Authors. Published by Elsevier GmbH. This is an ope
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abundant in certain tissues such as mouse brain [48].
4.4. Role of TCA cycle metabolites in chromatin demethylation
The involvement of a-KG in many cellular processes such as amino
acid and protein synthesis, tricarboxylic (TCA) cycle and nitrogen
transport, as well as its role in stabilizing immune system homeostasis
and modulating senescence, makes this compound a promising
candidate as a key sensor of the metabolic state of a cell and of the
whole organism [49]. Availability of a-KG for 2-OGDO enzymes could
regulate their activity on methylated chromatin. One observation
supporting this notion comes from a study in mESCs where decreasing
the a-KG/succinate ratio by manipulating medium composition led to a
global increase in H3K27 and DNA methylation levels [50]. In this
cellular model, maintaining the a-KG pool favours active demethylation
of repressive marks, contributing to a suppression of cellular
differentiation.
Adding to the complexity is the fact that succinate and fumarate, other
metabolites of the TCA cycle, can act as competitors of a-KG and thus
inhibit the activity of multiple 2-OGDO including TET1/2 and the JmjC
domain-containing histone demethylases KDM4A, KDM4D and
KDM4DL [51]. Tumors with impaired activity of succinate dehydro-
genase (SDH) or fumarate hydratase (FH) (converting succinate to
fumarate and fumarate to malate, respectively) accumulate up to
millimolar concentrations of succinate and fumarate [52,53]. HEK293T
cells ectopically expressing tumor-derived mutants of SDH and FH
showed decreased activity of KDMs manifested by increased
H3K4me1, H3K4me3, and H3K9me2 levels (in comparison to cells
expressing wild type SDH and FH), which was accompanied by up-
regulation of several HOXA genes. Isocitrate dehydrogenase (IDH) is
the enzyme catalysing reversible conversion of isocitrate to a-KG. In
humans, there are 3 isoforms of IDH. IDH1 is localized in the cytosol
and in peroxisomes while IDH2 and IDH3 are found mainly in mito-
chondria. IDH1 and IDH2 are NADPþ-dependent enzymes that function
as homodimers. They show high structural similarity and perform
analogous functions in different subcellular compartments. IDH3 dif-
fers structurally from the two other isoforms, working as hetero-
tetramer formed by the 2 a and 2 b subunits. IDH3 requires NADþ as a
cofactor and has a well established role in the TCA cycle [54]. Inter-
estingly, gain-of-function mutations in the catalytic site of IDH1/2 were
observed in some gliomas and acute myeloid leukaemia (AML) [55].
These mutations resulted in the ability of the enzymes to reduce a-KG
to the R enantiomer of 2-hydroxyglutarate (R-2HG), which is a
competitive inhibitor of JmjC KDMs and TET demethylases. These
neomorphic mutations correlate with an increase in global 5-mC levels
[56].
Taken together, impaired chromatin marks, and subsequently gene
expression, in some types of cancers can be caused by dysregulation
of TCA cycle enzymes affecting the physiological ratio of a-KG to 2-
OGDO inhibitors.
5. MECHANISMS OF HISTONE ACETYLATION
Protein acetylation normally occurs in two distinct forms. In humans,
more than 80% of proteins become co-translationally (and, to a
lesser extent, post-translationally) acetylated at their a-amino group
by N-terminal acetyltransferases. The second major type of acety-
lation occurs on the ε-amino group of Lys residues. The ﬁrst-
described evidence of Lys acetylation as a post-translational modi-
ﬁcation (PTM) comes from studies carried out in 1964, when thisn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 43
Reviewmark was found on histone tails isolated from calf thymus nuclei
[15]. Since then, many proteins carrying acetyl marks on Lys resi-
dues have been identiﬁed. While N-terminal acetylation is considered
to be largely irreversible, Lys acetylation is highly and dynamically
regulated by the competing activity of Lys acetyltransferases (KATs)
and Lys deacetylases (KDACs). Up to now, acetyl groups have been
found on more than 60 histone Lys residues. In the epigenetics ﬁeld,
therefore, KATs and KDACs are often called HATs and HDACs (for
‘histone acetyltransferases’ and ‘histone deacetylases’ respectively)
[57]. The majority of acetylated Lys within core histones is located in
their N-terminal tails and is usually correlated with active tran-
scription. These modiﬁcations include: K5 in H2A; K5, K12, K15, and
K20 in H2B; K4, K9, K14, K18, K23, and K27 in H3; K2, K8, K12, and
K16 in H4 [58]. In recent years, the role of acetylation within histone
globular domain in regulation of transcription has also been reported
[23,25,59]. At physiological pH, which is lower than the pI of Lys
(pILys ¼ 9.74), ε-amino groups are positively charged. Addition of an
acetyl group directly neutralizes the charge, potentially disrupting
electrostatic interactions with the negatively charged DNA and be-
tween adjacent nucleosomes [26]. This phenomenon can result in
‘opening’ of the chromatin making it more permissive to transcrip-
tion. Indirect effects of acetylation rely on the proteins or protein
complexes interacting with single modiﬁcations or combinations of
modiﬁcations. Acetyl groups are recognized and bound mainly by
bromodomain-containing proteins and protein complexes commonly
associated with promoting gene activation [60]. In humans there are
46 cytoplasmic and nuclear proteins containing a total of 61 bro-
modomains (BRDs) [61]. Among chromatin-related BRD-containing
proteins there are HATs (KAT2A, KAT2B, BRD9), histone methyl-
transferases (ASH1L, MLL), helicases (SMARCA), subunits of ATP-
dependent chromatin remodeling complexes (BAZ1B), transcrip-
tional coactivators (TRIMs, TAFs), transcriptional mediators (TAF1)
and nuclear scaffolding proteins (PBRM1) [62]. Therefore, the acet-
ylation pattern of histones can drive various downstream chromatin-
related events, contributing to changes in the transcription of
particular genes.Figure 3: Acetyl-CoA is a key metabolite linking metabolism and chromatin state. a. Sub
ACSS2 e acyl-coenzyme A synthetase short-chain family member 2, PDH e pyruvate d
Fluctuations of oxygen consumption and intracellular acetyl-CoA concentration during yeas
collected at indicated time points of YMC shows the induction of acetylation of selected H3
peak of intracellular acetyl-CoA concentration; OX e oxidative phase, RB e reductive bind
the authors and ELSEVIER.
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All KATs utilize acetyl-CoA as a donor of acetyl groups for protein
acetylation. Based on kinetic and binding parameters of mammalian
KATs, many of their activities should be sensitive to physiological
ﬂuctuations of acetyl-CoA [63]. Of note, many KATs are inhibited by the
product of the reaction, coenzyme A (CoA), and bind both acetyl-CoA
and CoA with similar afﬁnities [63]. Consequently, the ratio of these
metabolites and not solely the concentration of acetyl-CoA might be the
critical determinant for overall histone acetylation levels. Acetyl-CoA is
a key intermediate involved in many metabolic pathways including
cellular respiration, fatty acid, steroid and amino acid metabolism,
synthesis of ketone bodies and neurotransmitters and has also been
implicated in affecting the AMPK signaling pathway. Acetyl-CoA can be
synthesized in mitochondria and the cytosol, and, more recently,
synthesis in the nucleus has also been reported (see below)
(Figure 3A). In mitochondria, acetyl-CoA is a product of oxidative
decarboxylation of pyruvate by pyruvate dehydrogenase (PDH) and can
be used to fuel the TCA. Since there is no transporter of acetyl-CoA
across mitochondrial membranes, it is ﬁrst converted to citrate and
subsequently shuttled to the cytosol, where the reverse reaction to
generate acetyl-CoA again is catalyzed by ATP-citrate lyase (ACL). An
alternative source of cytosolic acetyl-CoA is the conversion of acetate
by acetyl-CoA synthetase (ACSS2). In line with this, an impact of
depletion of PDH, ACL, and ACSS2 on histone acetylation has been
observed in mammalian cells. Knockdown of ACSS2 in a murine
neuronal cell culture model leads to decreased level of H3K9ac and
H3K27ac [64]. Similarly, knockdowns of ACL in the human line
HCT116 and of the E1a1 subunit of PDH in HeLa S3 cells have a
profound effect on global acetylation of H2B, H3, and H4 and H3K18ac,
respectively [65,66]. The fact that knockdowns of various enzymes
affect histone modiﬁcations in different ways implies that depending
on the cell line, tissue, or metabolic state of a cell, the major source of
acetyl-CoA used for histone acetylation can be different.
Although acetyl-CoA can diffuse through nuclear pores, under speciﬁc
cellular conditions PDH, ACL and ACSS2 can transiently localize to the
nucleus and provide a local supply of acetyl-CoA for histone acetylationcellular pools of acetyl-CoA generated by different enzymes; ACL e ATP-citrate lyase,
ehydrogenase; dotted lines e passive diffusion, dashed line e multi-step process; b.
t metabolic cycle (YMC); c. Western blot analysis of cell extracts prepared from samples
Lys residues upon entry into RB phase. Histone acetylation is tightly correlated with the
ing phase, RC e reductive charging phase; c. reprinted from [68] with permission from
s is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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[64,65,67]. Such a mechanism increases the local concentration of
acetyl-CoA and could mediate more efﬁcient histone acetylation even if
the total cellular concentration of acetyl-CoA does not change
signiﬁcantly.
5.2. Physiological ﬂuctuations of acetyl-CoA levels
The ﬁrst clear evidence that acetyl-CoA availability correlates with
histone acetylation came from studies in Saccharomyces cerevisiae.
Yeast cells grown in a chemostat with limited glucose supply oscillate
synchronously between three distinctive metabolic phases in a so-
called ‘yeast metabolic cycle’ (YMC) (Figure 3B) [68,69]. The ﬁrst
oxidative phase (OX) is characterized by high oxygen consumption,
accumulation of building blocks, sulphur metabolism, as well as
ribosome and amino acid synthesis. Following, in the reductive-
building phase (RB), genes involved in mitochondria biogenesis and
responsible for DNA replication and cell division show the highest
expression. The last phase, reductive-charging (RC), is characterized
by intensive fatty acid oxidation and glycolysis [70]. Oscillations in
acetyl-CoA concentration follow the periodicity of YMC and peak at the
transition from OX to RB phase. Notably, acetylation levels of multiple
histone Lys residues (including K9, K14, K23, and K27 on H3 and K5,
K8, and K12 on H4) are tightly correlated with these changes in acetyl-
CoA levels (Figure 3C). Moreover adding acetate, ethanol, acetalde-
hyde, and lactate during a reductive phase forces yeast cells to rapidly
enter the oxidative phase, which is mirrored by acquiring additional
acetylation marks on histones [68]. This clearly demonstrates that, in
yeast, acetyl-CoA availability, which reﬂects the metabolic state of the
cell, is a crucial factor regulating histone acetylation levels. In mam-
mals, acetyl-CoA levels do not change in a regular manner but can vary
depending on the stage of development. Its abundance in mESCs is
about 8 times higher than in embryoid bodies induced by withdrawal of
LIF and application of retinoic acid for 7 days. Elevated levels of acetyl-
CoA is caused by increased Tdh expression in mESCs but whether this
has an impact on histone acetylation has not been investigated [36]. In
many cancer-derived cell lines, high levels of glucose in the medium
result in increased amounts of acetyl-CoA and are accompanied by an
elevation in global histone acetylation levels compared to non-cancer
cells. Notably, the exact effect of glucose supplementation on modi-
ﬁcation of speciﬁc histone Lys residues varies between cell lines [71].
This observation, that in many different cellular models the availability
of acetyl-CoA determines the level of histone acetylation, implies that
HATs are substrate limited enzymes that indeed respond to alterations
in the energetic state of the cell.
6. NADþ AS A COFACTOR OF SIRTUINS
6.1. NADþ dependent histone deacetylation
The oxidized form of nicotinamide adenine dinucleotide (NADþ) is an
important redox cofactor involved in catabolic and oxidative pathways
that accepts electrons in dehydrogenase reactions in the TCA cycle,
glycolysis and b-oxidation. Electrons from its reduced form, NADH, are
constantly removed and used in the mitochondrial electron transport
chain, resulting in oxidative phosphorylation and ATP generation. Apart
from its well established function in aerobic respiration, NADþ also
plays a role in calcium mobilization, thus in signaling pathways, ADP-
ribosylation, and protein deacetylation [72e74]. Histone deacetylases
(HDACs) are enzymes removing acetyl groups from histones and non-
histone proteins. So far, 18 HDACs have been identiﬁed in humans and
are grouped into four classes. The classical HDACs from class I, II, and
IV share a catalytic mechanism that requires a zinc ion and does not
depend on cellular metabolism-derived compounds; therefore,MOLECULAR METABOLISM 14 (2018) 39e52  2018 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comdiscussing these HDACs would be beyond the scope of this article.
HDACs from class III, named sirtuins after their homologue yeast
protein Sir2, are the only class that require NADþ as a cofactor;
therefore, they are the prime candidates to be metabolic sensors of
NADþ/NADH ﬂuctuations that couple the energetic state of the cell with
histone acetylation levels and gene expression [75,76]. Early work in
sirtuin studies showed that in S. cerevisiae NADþ-dependent histone
deacetylation by Sir2 is required for silencing at mating-type loci
Hidden MAT Left (HML) and Hidden MAT Right (HMR), at telomeres and
rDNA locus RDN1 [77]. Even though no direct link between the levels of
NADþ and silencing of these loci has been reported so far, the fact that
NADþ is required for particular changes in chromatin structure sup-
ports the concept of NADþ as one of the hubs of metabolism-to-
chromatin signaling.
Sirtuins are conserved in all species from bacteria, in which usually 1
or 2 sirtuins are present, to higher eukaryotes encoding multiple
versions of them. In mammals, there are 7 sirtuins: four nucleocyto-
solic (SIRT1, SIRT2, SIRT6, and SIRT7) and three mitochondrial (SIRT3,
SIRT4, SIRT5) [78e80]. SIRT activity is inhibited by several exogenous
small molecules (splitomicin, sirtinol, and its analogues, EX-527) and
also by NADH and NAM whose availability in mammals is tightly
coupled to NADþ metabolism [79,81], providing a particularly relevant
link with metabolism.
6.2. NADþ metabolism
In mammals, there are two pathways in which NADþ is generated
(Figure 4). The de novo pathway involves several steps of tryptophan
conversion and is rate limited by the enzyme catalyzing the ﬁrst step,
indoleamine-pyrrole 2,3-dioxygenase (IDO). In a salvage (recycling)
pathway, nicotinamide (NAM) generated by NADþ-consuming en-
zymes can be converted to nicotinamide mononucleotide (NMN) by
nicotinamide phosphoribosyltransferase (NAMPT), the rate limiting
enzyme in this salvage pathway, and further to NADþ by nicotinamide
mononucleotide adenylyltransferase (NMNAT) [82]. Upon inhibition of
NAMPT the lifespan of smooth muscle cells, previously shown to be
regulated by SIRT1, was reduced due to decreased NADþ production
[83]. This indicates that the turnover of NADþ by NAMPT is important
for proper SIRT1 function. There are three isoforms of NMNAT:
NMNAT1, found mostly in the nucleus, has been reported to interact
with SIRT1 in a complex present in chromatin and affecting histone
acetylation [84], whereas the roles of NMNAT2 (the cytosolic isoform)
and NMNAT3 (the mitochondrial isoform) in histone acetylation state
have not been investigated [85]. While the mitochondrial pool of NADþ
is preferentially used for ATP generation, its function in the nucleus is
not that explicit. Apart from its role in histone deacetylation, NADþ is
also used by poly(ADP-ribose) polymerases (PARP) acting in close
proximity to DNA and histones as well as by cyclic ADP-ribose syn-
thases, enzymes mainly localized on the cell surface but also present
in the nuclear inner envelope [86]. Therefore, the interaction of NMNAT
with particular chromatin complexes can be a mechanism favoring one
of the competing nuclear pathways.
6.3. NADþ levels sensed by nuclear enzymes
The circadian clock controls the rhythmic expression of many
eukaryotic genes and modulates various physiological functions by
feedback loops that involve a set of transcriptional factors and their
regulators. In mammals, the major regulators of circadian rhythms are
the heterodimeric transcription factors CLOCK and BMAL1 that activate
the expression of their transcriptional repressors Period (Per1, Per2)
and Cryptochrome (Cry1, Cry2) [87]. The core circadian clock ma-
chinery BMAL1:CLOCK controls, among others, the expression ofn access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 45
Figure 4: Nicotinamide Adenine Dinucleotide (NADþ) synthesis pathways. De novo synthesis NADþ from tryptophan (Trp) occurs mainly in the liver. The ‘salvage’ generation of
NADþ can result from either nicotinic acid (NA) or from a recycling pathway. Recycling of nicotinamide (NAM), the by-product of NADþ-dependent enzymes’ activity, is driven by
nicotinamide phosphoribosyltransferase (NAMPT) and nicotinamide mononucleotide adenylyltransferase (NMNAT) with nicotinamide mononucleotide (NMN) as an intermediary
product; CD38 e cyclic ADP-ribose hydrolase 1; IDO e indoleamine 2,3-dioxygenase; NAAD - nicotinic acid adenine dinucleotide; NADS e nicotinamide adenine dinucleotide
synthetase; NAMN e nicotinic acid mononucleotide; NAPRT e nicotinic acid phosphoribosyltransferase; PARPs e poly(ADP-ribose) polymerase; QAPRT e quinolinate phos-
phoribosyltransferase; SIRTs e sirtuins.
ReviewNAMPT. Although expression of sirtuins is constant, their HDAC activity
on H3 depends on the level of NAMPT and therefore oscillates in a
circadian manner mirroring the circadian ﬂuctuations of NADþ [88]. In
Clock knockout mice, upon inhibition of NAMPT, both circadian os-
cillations of NADþ and SIRT1 activity are largely lost [8]. Thus, SIRT1
activity seems to be regulated by circadian ﬂuctuations of NADþ.
Whether alterations of NADþ levels caused by starvation or calorie
restriction contribute signiﬁcantly to sirtuins’ activity is still contro-
versial. It is commonly accepted that even under changed metabolic
conditions the NADþ level is kept largely constant. However, it should
be noted that what can affect sirtuins’ activity is the [NADþ]:[NADH]
ratio. Studies in skeletal myoblasts showed that upon reducing glucose
concentration in culture medium from 25 mM to 5 mM, the
[NADþ]:[NADH] ratio increased from 5 to 15 [89]. Moreover, measuring
total cellular concentration of NADþ can mask slight but important
changes within subcellular compartments. A genetically encoded
ﬂuorescent biosensor, an excellent tool to measure intracellular con-
centrations of metabolites, determined the concentration of NADþ in
HEK293T nucleus to be 109 mM [90]. Interestingly, this value is very
close to the previously determined SIRT1 dissociation constant for
NADþ (Km ¼ 94 mM) [91]. Therefore, it is plausible that subtle alter-
ations in the nuclear concentrations of NADþ and its inhibitors, mainly
NADH and NAM, can be sensed by SIRT1 and thus, couple energetic
state with histone deacetylation.
As mentioned before, there are two predominant groups of nuclear
NADþ dependent enzymes: class III HDACs and PARPs. The majority of
PARP activity is distributed between PARP-1 and PARP-2 [92]. As the
Km of PARP-1 for NAD
þ is below its nuclear concentration it is unlikely
that the activity of PARP-1 is majorly modulated by ﬂuctuations of
NADþ [93]. However, PARP-1 activity can reduce the effective con-
centration of NADþ available for other enzymes. It has been shown that
the consumption of NADþ by constitutive activation of PARP-146 MOLECULAR METABOLISM 14 (2018) 39e52  2018 The Authors. Published by Elsevier GmbH. Thidecreases SIRT1 activity and causes dysregulation of SIRT1 target
genes in Xeroderma pigmentosum and Cockayne syndrome [94,95].
The PARP-2 dissociation constant for NADþ is within the range of
physiological changes in NADþ concentration (Km¼ 130 mM) and thus
PARP-2 can directly compete with SIRT1 for the ‘shared’ cofactor.
Taken together, there aremany lines of evidence indicating that NADþ is
a powerful signaling molecule transferring information about the en-
ergetic status of the cell to the chromatin level. However, precise
measurements of free NADþ and NADH in subcellular compartments
are still challenging. Further studies are also required to investigate both
the nuclear-wide and gene-speciﬁc effects of varying NADþ concen-
tration, as well as potential effects on ‘chromatin microdomains’.
7. SHORT CHAIN ACYL-COAS AS COFACTORS OF HISTONE
ACYLATIONS
Owing to the advantages of high-sensitivity mass spectrometry,
several new short-chain Lys acylations have recently been discovered
on histones: propionylation, butyrylation, crotonylation, 2-
hydroxyisobutyrylation, succinylation, malonylation, glutarylation, and
b-hydroxybutyrylation [96e102], and their roles in transcriptional
regulation are currently under careful investigation. Of note, the vast
majority of novel modiﬁcations were identiﬁed on Lys residues that can
also be acetylated. Different chemical properties of the various acyl
groups (Table 1) could allow various ‘reader’ proteins to interact
preferentially with speciﬁcally acylated Lys residues and thus add more
complexity to the previously established ‘histone code’ hypothesis
[103]. So far, speciﬁc ‘writers’ for distinct non-acetyl acylation have
not been identiﬁed, but rather several studies showed that HATs from
all three families can catalyze different acylations albeit with reduced
kinetics. A promising candidate for a short chain acyltransferase is
p300 that, due to the presence of a deep aliphatic pocket in its actives is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1 e Overview of different histone acylations and their functions in transcription; AA e amino acids, AKI e acute kidney injury, BCAA e branched-chain
amino acids, MSCI e meiotic sex chromosome inactivation, SCFA e short-chain fatty acids.
Type of acylation Chemical
properties of
acyl group
Modiﬁcation site on histones (mouse) Source of coAs Function References
Propionylation Hydrophobic Mainly N-terminal tails of H3 and H4 SCFA oxidation,
BCAA catabolism
Gene activation [109]
Butyrylation Hydrophobic Mainly N-terminal tails of H3 and H4, globular
domains of H3 and H4
SCFA oxidation,
BCAA catabolism
Gene activation, role in
spermatogenesis
[107]
2-Hydroxyisobutyrylation Polar Both N-terminal tails and globular domains BCAA catabolism Sustaining transcription
of genes escaping MSCI in
spermatogenesis
[100]
Succinylation Acidic Mainly globular domains of H3, H4, H1 SCFA oxidation Unknown
Malonylation Acidic Mainly globular domains of H3, H4, H1 Lipogenesis Unknown
Glutarylation Acidic Mainly C-terminal tail of H2B AA catabolism Unknown
Crotonylation Hydrophobic Both N-terminal tails and globular domains SCFA oxidation Signal dependent gene
activation, sustaining transcription
of genes escaping MSCI in
spermatogenesis, role in AKI-stress
induced gene activation
[66,97,102]
b-Hydroxybutyrylation Polar Both N-terminal teils and globular domains SCFA oxidation,
ketogenesis
Starvation induced gene activation [106]site, can accommodate substrates with increased acyl-chain length
like propionyl-, butyryl- and crotonyl-CoA [104]. Therefore the patterns
of histone Lys acylations could be established by competition of
different acyl-CoAs. Under this assumption, relative concentrations of
nuclear acyl-CoAs, generated in many metabolic pathways (Table 1),
could be an important player in sensing the metabolic state of a cell
and transferring this information to chromatin via distinct histone
acylations.
Short chain acyl-CoAs are metabolites involved in various anabolic and
catabolic pathways, the regulation of which depends on the energetic
state of the cell. When glucose sources are limited (e.g. upon fasting or
reduced intake of carbohydrates), ketone bodies (acetoacetate, b-
hydroxybutyrate [bOHB], and, to a lesser extent, acetone) are produced
by the liver, secreted, and serve as an alternative energy source in
extrahepatic tissues. In heart, brain, or muscles, bOHB can be con-
verted into acetyl-CoA to fuel the TCA cycle or, alternatively, it can be
used to generate bOHB-CoA e a cofactor for Lys b-hydroxybutyr-
ylation (bhb). Structural similarity of bOHB to the well-known HDAC
inhibitor butyrate implied its potential role in deacetylation inhibition,
which was conﬁrmed by an increase in H3K9 and H3K14 acetylation
levels upon treatment of HEK293 cells with increasing amounts of
bOHB [105]. In another study, however, starvation of mice or treatment
of cells with exogenous bOHB led to a 10-folde40-fold increase in
histone Kbhb levels whereas histone acetylation levels were not
dramatically changed [106]. These two observations suggest a dual
role for bOHB in the regulation of histone acylation statese as both an
HDAC inhibitor and a cofactor for b-hydroxybutyrylation. Interestingly,
increase in H3K9bhb upon starvation was positively correlated with
active gene expression [106]. Since its ﬁrst identiﬁcation, histone Kbhb
has been found on many Lys residues within all histones.
Histone Lys propionylation (pr), butyrylation (bu), and crotonylation (cr)
have also been linked with active transcription [66,96,107]. Butyrate is
naturally produced by the gastrointestinal microbiota or orally ingested
as a feed additive and serves as an important energy source for
colonocytes that use it as a substrate for b-oxidation and production of
acetyl-CoA [108]. While excess butyrate can be transported to the liver,
so far, the effect of butyrate has been explored mainly in colonocytes
where its inhibitory effect on class I and IIa HDACs favors histone
acetylation, and here it contributes to increased concentration ofMOLECULAR METABOLISM 14 (2018) 39e52  2018 The Authors. Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comacetyl-CoA via intensiﬁed b-oxidation. These mechanisms together
with increased H4 butyrylation could promote active transcription.
H3K14pr and H3K14bu are also novel acylation marks found alongside
H3K9ac within the promoters of active genes in mouse livers [109],
where the enrichment proﬁle of H3K14pr is strongly correlated with
transcriptional activity. Both of these H3K14 acylations could serve as
elements of a regulatory feedback mechanism signaling a certain
metabolic state to chromatin. In line with this, in a cell-free in vitro
transcription system, propionyl-CoA stimulates transcription to a
comparable extent as acetyl-CoA implying that ‘activation potential’ of
propionylated and acetylated histones is similar.
Apart from deacetylation, some sirtuins also show short chain
deacylation activity. Human SIRT1 can depropionylate H3K23 in vitro,
although the efﬁciency is lower than on an acetylated peptide [110].
Interestingly, mitochondrial SIRT5 displays higher demalonylation and
desuccinylation activity than deacetylation both in vitro and in vivo
[111] due to the presence of arginine and tyrosine residues in the acyl
pocket of SIRT5 that favor the accommodation of succinyl and malonyl
group. Therefore, careful structural analysis of active sites of nuclear
sirtuins could shed more light on their potential ‘additional’ activities
regulating histone short chain acylations.
8. OUTLOOK
As described in this review, there is growing evidence that various
chromatin-modifying enzymes can sense and respond to changes in
the levels of metabolites that are their cofactors, cosubstrates, or in-
hibitors. The fact that many histone acetyltransferases, histone
methyltransferases, DNA methyltransferases, and their corresponding
‘erasers’ can be (in contrast to kinases whose Km for ATP is signiﬁ-
cantly lower than its cellular concentration) substrate limited suggests
links between the metabolic condition of a cell, chromatin architecture,
and, hence, gene expression programs [112,113]. However, there are
many questions that remain open, including whether the altered levels
of metabolites have a global effect on chromatin or if speciﬁc genes
respond preferentially to these changes. The availability of genetically
encoded sensors providing localized measurements of metabolite
concentrations in vivo in subcellular compartments could help to
address this question and allow potential chromatin microdomains,n access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 47
Table 2 e Kinetic parameters and cellular concentrations of cofactors used by chromatin-modifying enzymes; CoA e coenzyme A, FAD/FADH2 e oxidized/
reduced form of ﬂavin adenine dinucleotide, MTAe 50-methylthioadenosine, NADþ/NADHe oxidized/reduced form of nicotinamide adenine dinucleotide, NAMe
nicotinamide, R-2HG - R enantiomer of 2-hydroxyglutarate, SAHe S-adenosylhomocysteine, SAMe S-adenosylmethionine, a-KGe a-ketoglutarate, 2-OGDOe
Fe2þ and a-KG dependent dioxygenases;* - histone acetyltransferases with reported acyltransferase activity: p300, MOF, PCAF, GCN5, TIP60.
Enzyme Cofactors
(endogenous
metabolites)
Inhibitors (endogenous
metabolites)
Km for
cofactor [mM]
Cellular/nuclear
concentration of
cofactor [mM]
Localisation of cofactor
production
References
Histone acetyltransferases Acetyl-CoA CoA, acyl-CoAs 0.2e46 2e20/? Cytosol, mitochondria, nucleus [71,101,117]
[118,119]
Histone methyltransferases SAM SAH, MTA 1.2e34.5 3.3e59/? Cytosol, nucleus [120e122]
DNA methyltransferases SAM SAH, MTA 0.1e21 3.3e59/? Cytosol, nucleus [122,123]
[124e126]
Histone acyltransferases* acyl-CoA CoA 0.1e1.5/? Cytosol, nucleus [101]
Sirtuins NADþ NAM, NADH 2.3e1400 300e2000/
87e136
Cytosol, mitochondria, nucleus [79,91,127,128]
[129e131]
Histone demethylases, 2-OGDO a-KG R-2HG, succinate, fumarate 9e37 110e260/? Cytosol, mitochondria [53,132e135]
Lsd1/2 FAD FADH2 ? ?/? Cytosol, mitochondria
DNA demethylation a-KG R-2HG, succinate, fumarate 35e75 110e260/? Cytosol, mitochondria [135e138]
Reviewdiscriminated by altered local concentrations of speciﬁc metabolites, to
be studied. Changes in e.g. the subnuclear distribution of particular
compounds could thus have an impact on chromatin modiﬁcations
even if their total cellular concentrations remain constant. Many of the
metabolites described in this article are of particular interest since
various studies, summarized in Table 2 have reported their cellular
concentrations to be within the range of dissociation constants of the
enzymes using them as cofactors. However, due to the facts that: (i)
certain cellular metabolites can serve also as inhibitors of these en-
zymes and (ii) kinetic parameters are mainly measured using in vitro
methods, obtained values may not fully reﬂect enzymes’ properties
in vivo. Further studies focused on enzymes’ kinetics and distribution
of metabolites in intracellular compartments are necessary and
constitute an interesting direction for future research.
Furthermore, as many of these key cellular metabolites are involved in
a plethora of pathways, translocation of the enzymes synthesising
them to the nucleus could be an important regulator of metabolic-
chromatin crosstalk. Interestingly, components of the pyruvate dehy-
drogenase complex (PDC) and a-ketoglutarate dehydrogenase (a-
KGDH) complex, which have previously been found mainly in mito-
chondria, have recently been discovered in the nucleus [67,114].
Therefore, the possibility that under certain conditions more enzymes
whose primary function was linked to other subcellular compartments
could be translocated to the nucleus, cannot be excluded. Further
investigation is needed to deﬁne signals triggering such translocations
and mechanisms involved in this processes.
Remarkably, there is also a clear disease relevance of the coupling
between the metabolic state and chromatin modiﬁcations. Multiple
connections between impaired activity of some TCA cycle enzymes
and various human diseases have been discovered in the last few
years. Loss- and gain-of-function mutations of SDH, FH, and IDH1/2,
respectively, have been associated with cancer phenotypes [53,56].
Although these mutations correlated in in vitro cellular models with
changes in histone and DNA methylation levels, the exact molecular
mechanisms in cancer tissues, and thus potential therapeutic ap-
proaches, are still unknown.
Beyond the usual suspects, novel modiﬁcations of DNA and RNA and
their ﬁrst links with metabolism have also recently been reported. Fat
mass and obesity-associated protein (FTO) has been shown to affect
human obesity and energy homeostasis [115]. Interestingly, FTO is a
demethylase with the highest activity towards m6A, the most abundant
RNA modiﬁcation in mammals. This indicates that at least some of the48 MOLECULAR METABOLISM 14 (2018) 39e52  2018 The Authors. Published by Elsevier GmbH. Thimany RNA modiﬁcations could also be linked to metabolism [116].
However, this ﬁeld of novel DNA/RNA modiﬁcations is still in its infancy.
We are getting more and more evidence of the threads linking
epigenetic modiﬁcations and metabolism. Uncovering the dynamic
relationship between various chromatin marks and the metabolic state
of the cell shaped by multiple factors is still challenging and metab-
oloepigenetic studies that comprehensively investigate all the epige-
netic changes (e.g. DNA, RNA and histone modiﬁcations, chromatin
architecture) caused by speciﬁc alterations of metabolic state (e.g. by
distribution and activity of metabolic enzymes and metabolites) would
be of great importance for the community. Adding to the challenge is
the fact that new players in the form of modiﬁcations, ‘writers’, and
‘erasers’ are constantly being identiﬁed. Nevertheless we anticipate
that the growing interest in the emerging ﬁeld of metaboloepigenetics
will lead us to a better understanding of these reciprocal links.
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